Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes

Experimental Hematology

Volumn 24, Issue 10, 1996, Pages 1258-1264

  Raghu, G ^a   Park, S W ^a   Roninson, I B ^a   Mechetner, E B ^a  

^a Oncotech Inc   (United States)

Author keywords

Interleukin 2; Lymphocytes; Multidrug resistance; P glycoprotein

Indexed keywords

GLYCOPROTEIN P; INTERLEUKIN 2; MONOCLONAL ANTIBODY; PHYTOHEMAGGLUTININ;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; CALCIUM; CELLS, CULTURED; DRUG RESISTANCE, MULTIPLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; P-GLYCOPROTEIN; PHYTOHEMAGGLUTININS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 0029821153     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)